1. Japan Stocks

  2. •

    Healthcare

  3. •

    Medical - Distribution
MediPal Holdings Corporation

MediPal Holdings Corporation

MAHLY
MediPal Holdings CorporationUS flagOther OTC
19.00
USD
- -
- -
3.89BMarket Cap
MediPal Holdings Corporation
MAHLY
(Other OTC)

Recent

price

19.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
11,352.79
11,707.58
12,391.12
13,042.86
12,701.33
13,373.23
13,531.42
13,942.84
14,269.53
15,062.49
15,293.99
15,673.89
16,002.93
16,803.45
17,609.69
- -
8,487.76
Revenue per Share
7.26
49.59
82.24
112.76
104.72
135.89
128.12
154.13
154.08
175.8
113.95
140.13
184.82
195.83
193.2
- -
115.98
Basic EPS, GAAP
114.12
-79.46
178.37
-109.8
288.69
-72.47
53.51
146.49
202.81
136.89
89.44
201.65
12.58
200.43
230.85
- -
- -
Free Cash Flow per Basic Share
18
17.99
18.2
21.98
23.99
25
30
32
36.11
40.04
42
42
46
52.78
60.14
- -
- -
Dividend per Share
772.54
803.5
896.08
991.98
1,063.79
1,172.28
1,276.32
1,400.89
1,541.07
1,726.87
1,846.46
1,943.25
2,081.9
2,180.09
2,328.57
- -
2,256.14
Book Value per Share
1,424.1
1,478.99
1,648.73
1,762.8
1,975.58
2,102.12
2,244.82
2,471.61
2,595.45
2,761.34
2,994.57
3,043.97
3,086.51
3,293.89
3,444.15
- -
3,418.61
Tangible Book Value per Share
235
235
227
226
226
226
226
226
223
216
210
210
210
212
208
206
210
Basic Weighted Avg Shares
2,662,887
2,750,215
2,810,914
2,947,738
2,872,913
3,028,235
3,064,041
3,146,341
3,181,935
3,253,122
3,211,173
3,290,921
3,360,008
3,558,732
3,671,328
- -
1,779,743
Sales/Revenue/Turnover
2.08
0.76
1.01
1.18
1.14
1.4
1.29
1.41
1.57
1.63
1.2
1.39
1.46
1.33
1.51
- -
1.5
Operating Margin (%)
14,020
12,724
12,618
13,147
12,325
12,459
13,794
15,374
13,928
14,687
14,792
14,338
14,648
17,982
18,417
- -
7,043
Depreciation Expense
1,704
11,650
18,655
25,485
23,687
30,771
29,011
34,780
34,359
37,968
23,926
29,423
38,806
41,474
40,279
- -
24,320
Net Income, GAAP
62.8
44.09
43.25
37.93
35.22
32.63
30.72
31.4
28.42
32.18
31.73
31.57
31.03
30.74
32.84
- -
30.23
Effective Tax Rate (%)
0.06
0.42
0.66
0.86
0.82
1.02
0.95
1.11
1.08
1.17
0.75
0.89
1.15
1.17
1.1
- -
1.37
Profit Margin (%)
103,988
117,478
131,801
133,724
150,912
159,158
166,901
193,802
202,785
200,579
221,278
200,950
207,761
236,471
273,299
- -
244,525
Working Capital
5,848
9,630
10,728
8,832
4,928
12,150
15,464
39,927
34,437
30,728
30,228
- -
- -
- -
- -
- -
- -
LT Debt
340,983
354,343
381,892
407,480
457,604
488,328
521,165
572,656
592,848
607,424
638,933
649,089
688,055
736,612
757,947
- -
757,655
Total Equity
5.32
2.96
3.86
4.84
4.49
5.49
5.02
5.09
5.54
5.54
3.96
4.56
4.85
4.52
4.91
- -
2.47
Return on Invested Capital (%)
0.17
3.4
5.22
6.78
5.6
6.95
5.65
6.12
4.97
4.98
2.72
3.6
5.23
5.37
4.75
- -
3.25
Return on Capital (%)
0.94
6.3
9.52
11.92
10.19
12.16
10.46
11.49
10.42
10.6
6.29
7.4
9.18
9.23
8.51
- -
5.27
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
210
- -
208
Market Capitalization
500,341
501,593
550,054

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
1,244,190
- -
1,306,803
Cash, Cash Equivalents & STI
230,470
- -
251,385
Accounts Receivable, Net
758,084
- -
771,809
Inventories
172,030
- -
197,578
Total Current Liabilities
1,007,719
- -
1,062,278
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
886,737
892,252
935,926
843,817
3,558,732
2025
- -
- -
- -
- -
3,671,328
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
52.32
- -
- -
- -
195.83
2025
- -
- -
- -
- -
193.2
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
52.78
2025
- -
- -
- -
- -
60.14
2026
- -
- -
- -
- -
- -
Similar Companies
Metrics in Balance N.V. (MLMIB.PA)
Exlites Holdings International, Inc. (EXHI)
Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)
Galenica AG (0ROG.L)
Nass Valley Gateway Ltd. (NVG.CN)
Wajd life trading Company (9647.SR)
Business
MediPal Holdings Corporation, a holding company listed on the Tokyo Stock Exchange Prime Market (ticker: 7459; OTC: MAHLY), oversees group companies engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, over-the-counter drugs, animal health products, and food processing raw materials across Japan. Its operations span three primary segments: the Prescription Pharmaceutical Wholesale Business, which procures and distributes prescription drugs, healthcare products for diagnostics, testing, treatment and administration including medical equipment, medical materials, and clinical diagnostic reagents to hospitals, clinics, and dispensing pharmacies; the Cosmetics, Daily Necessities and OTC Pharmaceutical Wholesale Business, which supplies cosmetics, daily necessities, and OTC pharmaceuticals to drugstores, home centers, convenience stores, and supermarkets; and the Animal Health Products and Food Processing Raw Materials Wholesale Business, which provides animal health products to veterinary clinics, farms, agricultural cooperatives, and processed food manufacturers, alongside raw ingredients for food processing. The company also supports healthcare services such as contract-based epidemiological and clinical studies, health insurance claims reviews, medical coding dispatch, outsourcing, remote education, and maintenance of computerized medical supply and master product databases for medical facilities; it operates through a nationwide network of over 300 bases from Hokkaido to Okinawa, targeting healthcare providers, retailers, and industrial customers primarily in Japan. Founded on October 8, 1898, and headquartered at 3-1-1 Kyobashi, Chuo-ku, Tokyo 104-8461 Japan, MediPal Holdings employs 13,061 consolidated staff as of March 31, 2025, with key subsidiaries including MEDICEO Corporation for prescription wholesaling, PALTAC Corporation for cosmetics and OTC, MEDIPAL FOODS CORPORATION for food materials, MP Gokyo Food & Chemical Co., Ltd., PRESUSCUBE Corporation for digital pharmacy management support, PreMedica Inc., FloraDiscovery Inc., Toshichi Inc., and others. Recent developments include the July 2024 additional investment making PRESUSCUBE Corporation a consolidated subsidiary to enhance digital transformation services for insurance pharmacies via tools like BHI management analysis and PRESUS business support systems, leveraging group logistics and networks; May 2024 acquisitions of PreMedica Inc. and FloraDiscovery Inc. as wholly owned subsidiaries; the September 2025 global licensing and Japan co-development deal with JCR Pharmaceuticals for JR-479; and ongoing equity buyback tranches under the May 2025 plan, aligning with the 2027 Medium-Term Vision for business innovation and growth in digital and healthcare efficiency.